#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rheumatoid arthritis Dupuytren's contracture Erdheim-Chester disease Neuroendocrine cell hyperplasia of infancy Primary mediastinal large B-cell lymphoma Usher's syndrome Muscular dystrophy Red blood cell abnormality Meningococcal immunisation Deafness bilateral Palmar-plantar erythrodysaesthesia syndrome Primary biliary cholangitis Pleomorphic liposarcoma Mucopolysaccharidosis II Medulloblastoma recurrent More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder Myxofibrosarcoma – Diagnostics Skin angiosarcoma – Basic Information Myelodysplastic syndrome with excess blasts – Treatment Chondrosarcoma metastatic – Trials in Disease Idiopathic inflammatory myopathy – Trials in Disease Waldenstrom’s macroglobulinaemia refractory Testicular leiomyosarcoma – Life with Disease Myelodysplastic syndrome with excess blasts – Life with Disease Breast angiosarcoma metastatic – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ivabradine Hydrochloride Flutemetamol (18F) CHONDROITIN SULFATE SODIUM Human Serum Albumin Avapritinib Rintatolimod Elexacaftor Dorocubicel SALICYLIC ACID Botulinum Toxin Type A Gemcitabine Hydrochloride Florbetaben (18F) Sodium Fluoride (18F) Tramadol Alitretinoin Taldefgrobep Alfa Efruxifermin Romiplostim F510/08 CLESROVIMAB More therapies…

    Learn about Your Condition

    Eosinophilic oesophagitis Hypopituitarism Hyperhidrosis Endometrial stromal sarcoma Oesophagogastroscopy Hand fracture Liver transplant Cytokine release syndrome Colonoscopy Congenital pseudarthrosis Migraine without aura Developmental hip dysplasia Thalassaemia beta Tooth loss Neuroblastoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Eplerenone for Improving Kidney Function in Patients Undergoing Kidney Transplantation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Eplerenone
    • Iohexol
    France

  • Study on Ethinylestradiol/Levonorgestrel and Vitamin E for Treating Menstrual and Perimenopausal Migraines in Women

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Alpha-Tocopherol
    • Ethinylestradiol
    • Levonorgestrel
    The Netherlands

  • Study Comparing Atezolizumab Alone and Atezolizumab with Bevacizumab for First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    Italy

  • Study on Statins for Frail Older Patients with Recent Ischemic Stroke or TIA: Fluvastatin, Simvastatin, Pravastatin Sodium, Atorvastatin, and Rosuvastatin Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Fluvastatin
    • Simvastatin
    • Atorvastatin
    The Netherlands

  • Study on Olaparib for Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Olaparib
    Italy

  • Study on Letrozole vs. Chemotherapy (Carboplatin and Paclitaxel) for Patients with Advanced Low-Grade Serous Ovarian Cancer with Hormone Receptors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer stage IV
    • Ovarian cancer stage III
    Investigated Drugs:
    • Carboplatin
    • Letrozole
    • Paclitaxel
    Czechia Italy
Previous Page
1 … 299 300 301 302 303 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!